Saurabh Saha
Chief Executive Officer chez CENTESSA PHARMACEUTICALS PLC
Fortune : 10 M $ au 31/03/2024
Profil
Saurabh Saha is the founder and the Chief Scientific Officer of BioMed Valley Discoveries, Inc., which was founded in 2008.
He is currently the Chief Executive Officer & Director at Centessa Pharmaceuticals Plc, Chief Executive Officer at Centessa Pharmaceuticals LLC, Director at Capella Bioscience Ltd., Director at Z Factor Ltd., Director at ApcinteX Ltd., Independent Director at Clarivate Plc starting in 2023, Director at Scorpion Therapeutics, Inc. starting in 2022, and an Associate Member at Harvard Medical School.
Dr. Saha previously served as the President, Chief Executive Officer & Director of Delinea, Inc. from 2016 to 2017, Director & Head-New Indications Discovery Unit at Novartis, Inc., and Senior Vice President-Research & Development at Bristol Myers Squibb Co. from 2017 to 2021.
He also held the position of Chief Medical Officer at Synlogic Operating Co., Inc. Dr. Saha obtained a graduate degree from the University of Oxford, an undergraduate degree from the California Institute of Technology, and a doctorate degree from The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2024 | 906 187 ( 1,01% ) | 10 M $ | 31/03/2024 | |
CLARIVATE PLC
0,00% | 04/05/2023 | 22 058 ( 0,00% ) | 163 891 $ | 31/03/2024 |
Postes actifs de Saurabh Saha
| Sociétés | Poste | Début |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Executive Officer | 01/01/2021 |
| CLARIVATE PLC | Director/Board Member | 04/05/2023 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Director/Board Member | 29/01/2021 |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Director/Board Member | 29/01/2021 |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Director/Board Member | 29/01/2021 |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Director/Board Member | 04/04/2022 |
| Harvard Medical School | Corporate Officer/Principal | - |
Centessa Pharmaceuticals, Inc.
 Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Chief Executive Officer | - |
Anciens postes connus de Saurabh Saha
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2021 |
| ░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - |
Formation de Saurabh Saha
| University of Oxford | Graduate Degree |
| California Institute of Technology | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CLARIVATE PLC | Commercial Services |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Entreprise privées | 9 |
|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Capella Bioscience Ltd.
Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Capella Bioscience Ltd. develops medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease. The company was founded by Steve Holmes in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
Delinea, Inc. (United States)
 Delinea, Inc. (United States) BiotechnologyHealth Technology Delinia, Inc. operates as a biotechnology company that develops novel therapeutics for the treatment of autoimmune diseases. Its main program is a molecule that potentiates and expands Regulatory T Cells, powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the path physiology of cancer and autoimmune disease. Delinia was founded by Michael Rosenblum and Jeffrey Greve in 2015 and is headquartered in Summit, NJ. | Health Technology |
Z Factor Ltd.
Z Factor Ltd. BiotechnologyHealth Technology Z Factor Ltd. operates as a drug discovery company. It identifies and develops therapeutic agents to treat alpha-1-antitrypsin deficiency. The company was founded by James Huntington in 2015 and is headquartered in Babraham, the united Kingdom. | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology ApcinteX Ltd. develops and markets anticoagulant APC pathway to treat haemophilia. The company is headquartered in London, the United Kingdom. | Health Technology |
BioMed Valley Discoveries, Inc.
 BioMed Valley Discoveries, Inc. Miscellaneous Commercial ServicesCommercial Services BioMed Valley Discoveries, Inc. is a biotechnology company that develops therapies for cancer, inflammation, and infectious disease. The private company is based in Kansas City, MO. The company was founded by Saurabh Saha. | Commercial Services |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Health Technology |
Centessa Pharmaceuticals, Inc.
Centessa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Centessa Pharmaceuticals Plc, Centessa Pharmaceuticals LLC is a private company that manufactures medicines. The company is based in Horsham, PA. The CEO of the company is Saurabh Saha. | Health Technology |
